GLP-1 Drugs and Liver Complications; Tracking Endoscopists’ Eyes; Peppermint for IBS

By News Health
1 hour Ago

(MedPage Today) — GLP-1 receptor agonists and SGLT2 inhibitors were associated with lower risks for liver-related events and hepatocellular carcinoma (HCC) in type 2 diabetes patients compared with other glucose-lowering therapies, a systematic…

Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/119651

Author :

Publish date : 2026-01-29 20:28:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cut Years Off College, Not Medical School

New Videos Show Alex Pretti Scuffle With Federal Officers 11 Days Before His Death

FDA OKs More Eye Drops That Can Replace Reading Glasses

Test for Early Pancreatic Cancer Suggests Potential for High-Risk Patients

U.S. Life Expectancy Hit an All-Time High in 2024, CDC Says

Overdose Risk as Quetiapine Supplied at Double Strength